With the audit process having been further complicated by the impact of the pandemic, ECO’s delayed results for the year ending Mar-20 and the half year ending Sep-20 have now been published. In headline terms, they are both very much in line with expectations. As previously discussed, trading suffered in H1-20 as the African Swine Fever outbreak in key market China impacted on demand. H2 was significantly stronger (60% of FY20 revenues) and that momentum has continued into FY21, with two signif ....
04 Feb 2021
FY20 & H1-21 results released
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
FY20 & H1-21 results released
ECO Animal Health Group plc (EAH:LON) | 85.5 0 0.0% | Mkt Cap: 57.9m
- Published:
04 Feb 2021 -
Author:
Chris Glasper | Edward Thomason -
Pages:
3
With the audit process having been further complicated by the impact of the pandemic, ECO’s delayed results for the year ending Mar-20 and the half year ending Sep-20 have now been published. In headline terms, they are both very much in line with expectations. As previously discussed, trading suffered in H1-20 as the African Swine Fever outbreak in key market China impacted on demand. H2 was significantly stronger (60% of FY20 revenues) and that momentum has continued into FY21, with two signif ....